Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 350 | 1,294 | 376 | 743 | 397 |
| Gross Profit | 350 | 1,294 | 376 | 743 | 397 |
| Operating Expenses | 7,642 | 8,746 | 7,948 | 6,076 | 4,588 |
| Operating Income | -7,292 | -7,453 | -7,572 | -5,334 | -4,192 |
| Other Income | -5 | -13 | 2 | -13 | 2 |
| Pre-tax Income | -7,297 | -7,465 | -7,570 | -5,347 | -4,189 |
| Net Income Continuous | -7,297 | -7,465 | -7,570 | -5,347 | -4,189 |
| Net Income | $-7,297 | $-7,465 | $-7,570 | $-5,347 | $-4,189 |
| EPS Basic Total Ops | -4.50 | -4.80 | -5.41 | -3.60 | -3.30 |
| EPS Basic Continuous Ops | -4.37 | -4.83 | -5.38 | -3.67 | -3.25 |
| EPS Diluted Total Ops | -4.50 | -4.80 | -5.41 | -3.60 | -3.30 |
| EPS Diluted Continuous Ops | -4.37 | -4.83 | -5.38 | -3.67 | -3.25 |
| EBITDA(a) | $-7,259 | $-7,421 | $-7,543 | $-5,313 | $-4,172 |